Tyrosine

protein tyrosine phosphatase non-receptor type 11 ; Homo sapiens







349 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34310951 CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3. 2022 Feb 1
2 35154156 The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation. 2022 1
3 35439551 The down-regulation of tyrosine phosphatase SHP2 activity is involved in the removal of surface AMPA receptors in long term depression. 2022 May 14 2
4 33413561 PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells. 2021 Jan 7 1
5 33562835 Polyphyllin D Shows Anticancer Effect through a Selective Inhibition of Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP2). 2021 Feb 5 1
6 33582386 Targeting SHP2 as a therapeutic strategy for inflammatory diseases. 2021 Mar 15 2
7 33727228 Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance. 2021 Jun 1 1
8 33732417 Phosphatase Shp2 regulates biogenesis of small extracellular vesicles by dephosphorylating Syntenin. 2021 Mar 1
9 33777680 A multifunctional cross-validation high-throughput screening protocol enabling the discovery of new SHP2 inhibitors. 2021 Mar 3
10 34338914 Exploring the cause of the dual allosteric targeted inhibition attaching to allosteric sites enhancing SHP2 inhibition. 2021 Aug 2 1
11 31561841 Regulation of peripheral and central immunity: Understanding the role of Src homology 2 domain-containing tyrosine phosphatases, SHP-1 & SHP-2. 2020 Jan 1
12 31784318 Development and structure-activity relationship study of SHP2 inhibitor containing 3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene. 2020 Jan 1 2
13 31838080 Targeting SHP2 as a promising strategy for cancer immunotherapy. 2020 Feb 1
14 31953320 A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors. 2020 Feb 28 2
15 31954180 A new abietane diterpenoid from Ajuga ovalifolia var. calantha induces human lung epithelial A549 cell apoptosis by inhibiting SHP2. 2020 Mar 2
16 31978797 Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4. 2020 Mar 2
17 32024694 A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2). 2020 Mar 13 2
18 32061959 Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. 2020 Mar 15 2
19 32076487 Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR. 2020 Jan 21 1
20 32236803 1H, 13C, 15N chemical shift assignments of SHP2 SH2 domains in complex with PD-1 immune-tyrosine motifs. 2020 Oct 3
21 32363035 SHP2-Independent Tyrosine Dephosphorylation of Cortactin and Vinculin during Infection with Helicobacter pylori. 2020 Apr 7 1
22 32391629 Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. 2020 Jun 8 1
23 32460492 Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. 2020 Oct 22 3
24 32467571 Loss of tyrosine phosphatase SHP2 activity promotes growth of colorectal carcinoma HCT-116 cells. 2020 May 29 1
25 32545165 Understanding the Mechanism of Recognition of Gab2 by the N-SH2 Domain of SHP2. 2020 Jun 11 1
26 32765928 LEOPARD Syndrome with PTPN11 Gene Mutation in Three Family Members Presenting with Different Phenotypes. 2020 Dec 1
27 32910655 Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. 2020 Nov 25 2
28 32921395 Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds. 2020 Nov 2
29 33002410 Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation. 2020 Oct 15 2
30 33113413 Scaffold-based selective SHP2 inhibitors design using core hopping, molecular docking, biological evaluation and molecular simulation. 2020 Dec 2
31 30573803 A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome. 2019 Apr 1
32 30688462 Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors. 2019 Feb 28 1
33 30696956 Src and SHP2 coordinately regulate the dynamics and organization of vimentin filaments during cell migration. 2019 May 1
34 31184863 Myristoylation-Dependent Palmitoylation of the Receptor Tyrosine Kinase Adaptor FRS2α. 2019 Jun 25 1
35 31373232 SHP2 inhibitor specifically suppresses the stemness of KRAS-mutant non-small cell lung cancer cells. 2019 Dec 1
36 31562133 Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions. 2019 Dec 19 2
37 31807022 Gain-Of-Function E76K-Mutant SHP2 Promotes Cell Proliferation, Metastasis, And Tumor Growth In Glioblastoma Through Activation Of The ERK/CREB Pathway. 2019 1
38 28804122 SHP2 is required for BCR-ABL1-induced hematologic neoplasia. 2018 Jan 1
39 29282323 Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor. 2018 Jan 16 1
40 29408202 Resolvin D1 blocks H2O2-mediated inhibitory crosstalk between SHP2 and PP2A and suppresses endothelial-monocyte interactions. 2018 Mar 1
41 30018082 Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia. 2018 Jul 17 3
42 30047735 Mechanism of Folding and Binding of the N-Terminal SH2 Domain from SHP2. 2018 Dec 13 1
43 30129165 Exploring the effect of E76K mutation on SHP2 cause gain-of-function activity by a molecular dynamics study. 2018 Dec 8
44 30227954 Transcriptional Co-activator Functions of YAP and TAZ Are Inversely Regulated by Tyrosine Phosphorylation Status of Parafibromin. 2018 Mar 23 1
45 30333625 LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. 2018 Oct 1
46 30374120 Evaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate. 2018 Oct 29 1
47 27696702 Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 2017 Jan 1
48 28208810 Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells. 2017 Feb 13 3
49 28209599 Role of SHP2 protein tyrosine phosphatase in SERT inhibition by enteropathogenic E. coli (EPEC). 2017 May 1 3
50 28332308 CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells. 2017 Apr 1